Weight loss is a critical factor to reduce inflammation
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
BACKGROUND Chronic inflammation is a process sustained by the augmentation of circulating cytokines level and C-reactive protein (CRP). Adipocytes and adipose tissue infiltration with inflammatory cells, are an important source of adipokines production, and their expansion due to overnutrition is responsible for increased in inflammation. The reduction of body fat following both controlled diets or gastric surgery can be favorable in the reduction of pro-inflammatory cytokines. METHODS A systematic literature search performed using PubMed, Google Scholar and Cochrane Library database screened for clinical and randomized controlled trials (RCTs) using the combination of the following keywords: "weight loss, inflammation," "restricted diet, anti-inflammatory effect." Studies including diet intervention, weight loss after gastric surgery have been included. Multidisciplinary program with the addition of food supplements, exercise, or drugs have been excluded to avoid their interference with the regulation inflammatory markers. RESULTS Out of 967 articles found, 76 were selected, including a total of 6742 patients with a mean age of 44.0 ± 3,3 years and a BMI of 33 ± 6.6. The observation period ranged from 3 weeks up to two years with an average weight loss per month of 1.1 kg. In most of the studies, it was found that weight loss caused a significant reduction of plasma level of inflammatory cytokines although three studies did not see any effect. CONCLUSIONS In obese and overweight subjects weight loss, induced both by energy-restricted diet or surgery, is a determinant factor for reducing the level of pro-inflammatory markers. Hypocaloric diet has an anti-inflammatory effect independent of the diet composition which can play an important role in the prevention of chronic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 3×
“Physiological mitochondrial production of ROS in WAT promotes adipocytes differentiation [140] and modulates adipocyte apolipoprotein E (apoE) production, which has the function to facilitate lipid flux [141].”
BackgroundIL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769 · cited 1×
“Chronic inflammation represents the primary source of metabolic disorders promoting the onset of insulin resistance [1,2], atherosclerosis [3], neurodegenerative and cardiovascular disease (CVD) [4], obesity and cancer [5,6].”
BackgroundInflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176 · cited 2×
“Adiponectin activity is mediated by the receptors, AdipoR1 and AdipoR2 [119] which are essential in the regulation of inflammation and insulin sensitivity [120].”
BackgroundAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“Adiponectin level is low in obese subjects [125] in particular high molecular weight (HMW) adiponectin which is determinant in the development of obesity and linked to insulin resistance [120] and to the incidence of type-2 diabetes [126].”
BackgroundKanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966 · cited 1×
“The reduced caloric intake is themost critical factor to improve cellular metabolism and mitochondrial function compared to exercise and gastric bypass to induce weight loss over the term [146].”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799 · cited 1×
“Although in patients affected by metabolic syndrome exercise training improved some metabolic parameter [164,165], weight loss due to a restricted diet program determined superior effects [166].”
BackgroundPrice, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“SIRT1 closely works with AMPK mediating calcium-dependent mechanism which stimulates mitochondrial proliferation and function [183].”
BackgroundAhima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
Gerhart‐Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S., Mostoslavsky, R., Alt, F. W., Wu, Z., & Puigserver, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601633 · Cited by 1,294 · cited 6×
“[179] Chaube B, Malvi P, Singh SV, Mohammad N, Viollet B, Bhat MK. AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1alpha-mediated mitochondrial biogenesis.”
BackgroundInfluentialMetabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Scarpulla, R. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.019 · Cited by 1,281
Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.-L., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2277 · Cited by 1,164
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Makki, K., Froguel, P., & Wolowczuk, I. (2013) · ISRN Inflammation · doi:10.1155/2013/139239 · Cited by 1,085 · cited 6×
“Clifton, 2006 [221] 55 49.3 31.8 Randomized Controlled Trial Kcal 1434 3 6.3 NC ___ CRP, PAI-1 and sICAM1 reduced.”
BackgroundInfluentialInterplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080 · cited 1×
“Themetabolic effect of protein ingestions seems to be correlated to the content of branched chain amino acids which have been involved in the risk of diabetes, obesity and cardiovascular disease [190].”
BackgroundGlycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies
Barclay, A. W., Petocz, P., McMillan-Price, J., Flood, V. M., Prvan, T., Mitchell, P., & Brand-Miller, J. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.627 · Cited by 1,061 · cited 1×
“Although the glycemic index of the carbohydrates of the diet seemed important in the treatment of metabolic diseases [196], particularly in type-2 diabetes [197], Kristo et al.”
BackgroundAdiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6
Park, H. S., Park, J. Y., & Yu, R. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.007 · Cited by 964
Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S. C., de las Fuentes, L., He, S., Okunade, A. L., Patterson, B. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.005 · Cited by 886
Stern, L., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, M., Gracely, E. J., & Samaha, F. F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00007 · Cited by 831 · cited 1×
“Low carbohydrates diet is more efficient on metabolic improvement compared to conventional weight loss diet, also after adjustment for weight loss differences [158].”
BackgroundGlycemic index: overview of implications in health and disease,,,
Jenkins, D. J., Kendall, C. W., Augustin, L. S., Franceschi, S., Hamidi, M., Marchie, A., Jenkins, A. L., & Axelsen, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.266s · Cited by 827
Ajala, O., English, P., & Pinkney, J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.042457 · Cited by 821 · cited 1×
“[215] found that weight loss improved the markers of inflammation in patients with cardiovascular risk independently from the type of diet, both a low-carbohydrate, low-glycemic index, Mediterranean, and high-protein diets.”
BackgroundInflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820
Weight loss regulates inflammation‐related genes in white adipose tissue of obese subjects
ClÉment, K., Viguerie, N., Poitou, C., Carette, C., Pelloux, V., Curat, C. A., Sicard, A., Rome, S., Benis, A., Zucker, J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2204com · Cited by 640
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616 · cited 1×
“The impaired mitochondrial function inWAT is determinant in the development of obesity and type-2 diabetes in obese ob/ob mice [130] and human obese subjects [131].”
BackgroundWeight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541
Aging, adiposity, and calorie restriction
Fontana, L. (2007) · JAMA · doi:10.1001/jama.297.9.986 · Cited by 526
Obesity and inflammation: the effects of weight loss
Forsythe, L. K., Wallace, J. M. W., & Livingstone, M. B. E. (2008) · Nutrition Research Reviews · doi:10.1017/s0954422408138732 · Cited by 381 · cited 1×
“A direct relationship between fat mass loss and decreased inflammation has been demonstrated [160,161].”
BackgroundGlycemic index: overview of implications in health and disease,,,
Jenkins, D. J., Kendall, C. W., Augustin, L. S., Franceschi, S., Hamidi, M., Marchie, A., Jenkins, A. L., & Axelsen, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76/1.266s · Cited by 379 · cited 1×
“Although the glycemic index of the carbohydrates of the diet seemed important in the treatment of metabolic diseases [196], particularly in type-2 diabetes [197], Kristo et al.”
BackgroundMitochondria are impaired in the adipocytes of type 2 diabetic mice.
Choo, H.-J., Kim, J.-H., Kwon, O.-B., Lee, C. S., Mun, J. Y., Han, S. S., Yoon, Y.-S., Yoon, G., Choi, K.-M., & Ko, Y.-G. (2006) · Diabetologia · doi:10.1007/s00125-006-0170-2 · Cited by 365 · cited 1×
“In fact, the mitochondria activity increased in adipocytes of db/db mice after the treatment with rosiglitazone, a drug that improves insulin activity and glucose control [134].”
BackgroundLipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343 · cited 1×
“Weight loss has a significant effect on mitochondrial function activating the lipolysis and fatty acids oxidation [167].”
BackgroundAutophagy is Required for Dietary Restriction-Mediated Life Span Extension in C. elegans
Jia, K., & Levine, B. (2007) · Autophagy · doi:10.4161/auto.4989 · Cited by 341
Heilbronn, L. K., Noakes, M., & Clifton, P. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.968 · Cited by 331 · cited 1×
“Heilbronn, 2001 [67] 83 W healthy 48 33.”
Salas-Salvadó, J., Garcia-Arellano, A., Estruch, R., Marquez-Sandoval, F., Corella, D., Fiol, M., Gómez-Gracia, E., Viñoles, E., Arós, F., Herrera, C., et al. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602762 · Cited by 295 · cited 1×
“2 35 Double-Blind 800 kcal/day 2 36 7,7 14,3 __ __ 10% of weight loss determines an improvement in adipnectin level, CRP and fibrinogen Salas-Salvad o, 2008 [28] 772 (339 M) (433W) 67.”
Essential role of mitochondrial function in adiponectin synthesis in adipocytes
Koh, E. H., Park, J.-Y., Park, H.-S., Jeon, M. J., Ryu, J. W., Kim, M., Kim, S. Y., Kim, M.-S., Kim, S.-W., Park, I. S., et al. (2007) · Diabetes · doi:10.2337/db07-0510 · Cited by 275
Illán-Gómez, F., Gonzálvez-Ortega, M., Orea-Soler, I., Alcaraz-Tafalla, M. S., Aragón-Alonso, A., Pascual-Díaz, M., Pérez-Paredes, M., & Lozano-Almela, M. L. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0643-y · Cited by 265
Whole-Grain, Bran, and Cereal Fiber Intakes and Markers of Systemic Inflammation in Diabetic Women
Qi, L., van Dam, R. M., Liu, S., Franz, M., Mantzoros, C., & Hu, F. B. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1903 · Cited by 261
Marin, T. L., Gongol, B., Zhang, F., Martin, M., Johnson, D. A., Xiao, H., Wang, Y., Subramaniam, S., Chien, S., & Shyy, J. Y.-J. (2017) · Science Signaling · doi:10.1126/scisignal.aaf7478 · Cited by 257
Christiansen, T., Paulsen, S. K., Bruun, J. M., Pedersen, S. B., & Richelsen, B. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00574.2009 · Cited by 255 · cited 2×
“Although in patients affected by metabolic syndrome exercise training improved some metabolic parameter [164,165], weight loss due to a restricted diet program determined superior effects [166].”
BackgroundInfluentialMacronutrient balance, reproductive function, and lifespan in aging mice
Solon-Biet, S. M., Walters, K. A., Simanainen, U. K., McMahon, A. C., Ruohonen, K., Ballard, J. W. O., Raubenheimer, D., Handelsman, D. J., Le Couteur, D. G., & Simpson, S. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422041112 · Cited by 243 · cited 1×
“Diets containing a protein/ carbohydrates ratio of 1:13 in males and 1:11 for females in rats achieved the maximal longevity [188].”
BackgroundMeydani, S. N., Das, S. K., Pieper, C. F., Lewis, M. R., Klein, S., Dixit, V. D., Gupta, A. K., Villareal, D. T., Bhapkar, M., Huang, M., et al. (2016) · Aging · doi:10.18632/aging.100994 · Cited by 228
Itariu, B. K., Zeyda, M., Hochbrugger, E. E., Neuhofer, A., Prager, G., Schindler, K., Bohdjalian, A., Mascher, D., Vangala, S., Schranz, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037432 · Cited by 227 · cited 1×
“In obese nondiabetic patients, high doses of n-3 PUFA regulated the systemic inflammation [208], however, TelleHansen et al.”
BackgroundHermsdorff, H. H. M., Zulet, M. Á., Abete, I., & Martínez, J. A. (2011) · European Journal of Nutrition · doi:10.1007/s00394-010-0115-x · Cited by 223
AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise
Ruderman, N. B., Park, H., Kaushik, V. K., Dean, D., Constant, S., Prentki, M., & Saha, A. K. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01164.x · Cited by 217
Tay, J., Thompson, C. H., Luscombe‐Marsh, N. D., Wycherley, T. P., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13164 · Cited by 215
Dietary Protein to Carbohydrate Ratio and Caloric Restriction: Comparing Metabolic Outcomes in Mice
Solon-Biet, S. M., Mitchell, S. J., Coogan, S. C. P., Cogger, V. C., Gokarn, R., McMahon, A. C., Raubenheimer, D., de Cabo, R., Simpson, S. J., & Le Couteur, D. G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.007 · Cited by 207
Dahlman, I., Forsgren, M., Sjögren, A., Nordström, E. A., Kaaman, M., Näslund, E., Attersand, A., & Arner, P. (2006) · Diabetes · doi:10.2337/db05-1421 · Cited by 184 · cited 1×
“Notably, the alteration in mitochondrial DNA in humans is a consequence of diabetes and not of obesity [132] evidencing that the alteration of glucose control is the principal deleterious mechanism on mitochondria.”
BackgroundGögebakan, Ö., Kohl, A., Osterhoff, M. A., van Baak, M. A., Jebb, S. A., Papadaki, A., Martinez, J. A., Handjieva-Darlenska, T., Hlavaty, P., Weickert, M. O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.033274 · Cited by 180
You, T., Yang, R., Lyles, M. F., Gong, D., & Nicklas, B. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2004 · Cited by 173 · cited 1×
“In obese patients, the reduction of body fat mass, in particular visceral fat, improves mitochondrial function in adipocytes and decrease cytokines production [135,136] playing an important role in the control of the inflammatory response [136,137], vascular endothelial function [138], and immunity [137].”
BackgroundSeshadri, P., Iqbal, N., Stern, L., Williams, M., Chicano, K. L., Daily, D. A., McGrory, J., Gracely, E. J., Rader, D. J., & Samaha, F. F. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.009 · Cited by 169
Dietary strategies implicated in the prevention and treatment of metabolic syndrome
De la Iglesia, R., Loria-Kohen, V., Zulet, M., Martinez, J., Reglero, G., & Ramirez de Molina, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111877 · Cited by 168 · cited 1×
“Weight loss induced by calorie restriction diet represents the most effective treatment for patients with metabolic disorders [147] reducing the visceral adiposity, and the incidence of type-2 diabetes, and inflammation [147,148].”
BackgroundFan, J., Song, Y., Wang, Y., Hui, R., & Zhang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052182 · Cited by 148 · cited 1×
“An excessive intake of dietary carbohydrates [192,193] and a higher plasma glucose level has detrimental effects on the cardiovascular system and the progression of chronic diseases [194] with increased incidence of all-cause mortality in CVD patients.”
BackgroundFisher, G., Hyatt, T. C., Hunter, G. R., Oster, R. A., Desmond, R. A., & Gower, B. A. (2011) · Obesity · doi:10.1038/oby.2010.310 · Cited by 103
Gögebakan, Ö., Osterhoff, M. A., Schüler, R., Pivovarova, O., Kruse, M., Seltmann, A.-C., Mosig, A. S., Rudovich, N., Nauck, M., & Pfeiffer, A. F. H. (2015) · Diabetologia · doi:10.1007/s00125-015-3618-4 · Cited by 95
Cited by
Lifestyle interventions for the prevention and treatment of hypertension
Valenzuela, P. L., Carrera-Bastos, P., Gálvez, B. G., Ruiz-Hurtado, G., Ordovas, J. M., Ruilope, L. M., & Lucia, A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00437-9 · Cited by 354
Kenđel Jovanović, G., Mrakovcic-Sutic, I., Pavičić Žeželj, S., Šuša, B., Rahelić, D., & Klobučar Majanović, S. (2020) · Nutrients · doi:10.3390/nu12113583 · Cited by 73
“In the present study, the biomarkers of inflammation were significantly reduced in both groups, similarly or slightly greater in comparison to some other studies that evaluated the impact of diet on markers of inflammation [78,79].”
InfluentialLane, M., Howland, G., West, M., Hockey, M., Marx, W., Loughman, A., O’Hely, M., Jacka, F., & Rocks, T. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.04.006 · Cited by 50
Ezzati, A., Rosenkranz, S. K., Phelan, J., & Logan, C. (2023) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.09.013 · Cited by 45
Metadata
- Authors
- Bianchi, V. E.
- Venue
- Clinical Nutrition ESPEN
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 28
- Pages
- 21-35
- ISSN
- 2405-4577 (ISSN-L)
- OpenAlex
- W2890416444
- Cited by
- 134
- References
- 63
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.